CN · Field Sheet
FIELD SHEET — ASTAXANTHIN MFI-ASTAXA-20261016-FS
Survey index / ASTAXANTHIN

Astaxanthin.

Haematococcus pluvialis (microalgal source)
Microalgal carotenoid pigment; oxidative-stress, skin, and exercise-recovery literature.
SEALED MFI-ASTAXA-20261016-FS · RELEASED 2026-10-16
SHEET FINGERPRINTMFI-ASTAXA-20261016-FS
706INCLUDED
2,017EXCLUDED
47DUPLICATE
163NON-TRANSFERABLE
2OUT OF CUTOFF
Survey totalsScroll ↓
2,935records surveyed
706studies
18claims graded
251observations
10,736graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-b09a93247ee8c268GRADE VERY_LOW
astaxanthin constituents — antioxidant
direction BENEFIT · dose 0.58 mg/kg; 1.5 g/kg; 10 mg/kg; 12 mg; 150 mg/kg; 18 mg; 20 mg/kg; 219.2 mg/kg; 37.5 mg; 4 g/kg; 40 mg/kg; 50 mg/kg; 60 mg/kg; 640 mg/kg; 8 mg; 9 mg · duration 10 days; 21 days; 24 weeks; 28 days; 42 days; 56 days; 6 weeks; 60 day; 8 weeks; 90 days
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
48bound studies
Bound studies (4 shown of 48)
STU-0c9985d80f49c1fb
ANIMAL · ANIMAL · 2025 · 8 weeks · RoB INSUFFICIENT_INFORMATION
4 endpoints
STU-0ea1d3e9123fef8c
ANIMAL · ANIMAL · 2026 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-1b3c91157c60bb38
ANIMAL · ANIMAL · 2025 · RoB SOME_CONCERNS
6 endpoints
STU-1cca1ad9af62fc40
ANIMAL · ANIMAL · 2023 · RoB INSUFFICIENT_INFORMATION
1 endpoints
Quantitative observations
n 403 · validated
dose 10 mg/kg · validated
dose 20 mg/kg · validated
Opposition screen
SCREEN · 60 candidates considered · 3 bound as opposing
SYNTHESIS SYN-98f59dca08f89f — outcome QUALITATIVE_ONLY · BENEFIT ×48 · not_assessed_quantitatively · 48 members
PROVENANCE → epmc:39613170, epmc:41110564, epmc:40491554 · PKG 9e75edacf8ae865d…
CLAIM · CLM-5bad96f2d6e3cc76GRADE VERY_LOW
astaxanthin constituents — inflammation
direction BENEFIT · dose 1.5 g/kg; 10 mg/kg; 12 mg; 20 mg; 4 g/kg; 500 mg/kg; 640 mg/kg; 8 mg · duration 10 days; 24 weeks; 28 days; 35 days
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
24bound studies
Bound studies (4 shown of 24)
STU-0a32146c7087a0eb
ANIMAL · ANIMAL · 2026 · RoB INSUFFICIENT_INFORMATION
5 endpoints
STU-1b3c91157c60bb38
ANIMAL · ANIMAL · 2025 · RoB SOME_CONCERNS
6 endpoints
STU-1cf30c0db7078e55
ANIMAL · ANIMAL · 2025 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-1e2180418f465eb5
META_ANALYSIS · HUMAN · 2026 · RoB INSUFFICIENT_INFORMATION
5 endpoints
Quantitative observations
n 403 · validated
effect p < 0.05 | p < 0.05 · failed extraction
dose 10 mg/kg · validated
Opposition screen
SCREEN · 32 candidates considered · 3 bound as opposing
SYNTHESIS SYN-9cc0ffaba3f886 — outcome QUALITATIVE_ONLY · BENEFIT ×24 · not_assessed_quantitatively · 24 members
PROVENANCE → epmc:42070604, epmc:40491554, epmc:40444055 · PKG 9e75edacf8ae865d…
Bounded preview — representative records only. The full release ships 18 claims and 251 observations.